[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352563-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352563-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","roburic-acid-as-a-therapeutic-candidate-antiproliferative-activity-and-secondary-cell-death-response-in-colorectal-cancer-cells","Roburic Acid as a Therapeutic Candidate - Antiproliferative Activity and Secondary Cell Death Response in Colorectal Cancer Cells","","Natural compounds are increasingly recognized as valuable sources of pharmacologically active agents for cancer therapy. Roburic acid (RA), a tetracyclic triterpenoid, is investigated here for its mechanisms in colorectal cancer cells. RA markedly suppresses proliferation via G0/G1 cell cycle arrest and reduces mitochondrial membrane potential. These effects occur without intracellular ROS generation and without DNA strand breaks, indicating a non-pro-oxidant and non-genotoxic profile. Apoptosis appears mainly at higher doses and prolonged exposure, varying by cell line and assay.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/roburic-acid-as-a-therapeutic-candidate-antiproliferative-activity-and-secondary-cell-death-response-in-colorectal-cancer-cells/352563/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/roburic-acid-as-a-therapeutic-candidate-antiproliferative-activity-and-secondary-cell-death-response-in-colorectal-cancer-cells/352563.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does roburic acid (RA) affect colorectal cancer cell proliferation?","Question",{"text":63,"@type":64},"RA markedly suppresses CRC cell proliferation, primarily by inducing G0/G1 cell cycle arrest and downregulating key proliferation markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What mitochondrial and oxidative stress effects does RA cause?",{"text":68,"@type":64},"RA causes an early reduction in mitochondrial membrane potential, indicating mitochondrial dysfunction, while occurring without intracellular reactive oxygen species (ROS) generation.",{"name":70,"@type":61,"acceptedAnswer":71},"Is RA genotoxic or does it induce DNA strand breaks?",{"text":72,"@type":64},"RA shows a non-genotoxic profile: its effects occur without induction of DNA strand breaks, supporting further investigation as a non-genotoxic anticancer compound.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352563,1790964979,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nRoburic Acid as a Therapeutic Candidate: Antiproliferative Activity and Secondary Cell Death Response in Colorectal Cancer Cells  \nAdrianna Gieleci ´nska 1,2, Mateusz Kciuk 1, *, Renata Gruszka 1, Sebastian Wawrocki 3 and Renata Kontek 1  \nAcademic Editor: Carmine Stolfi  \nReceived: 9 February 2026  \nRevised: 4 March 2026  \nAccepted: 6 March 2026  \nPublished: 8 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Molecular Biotechnology and Genetics, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland; [adrianna.gielecinska@edu.uni.lodz.pl](adrianna.gielecinska@edu.uni.lodz.pl) (A.G.); [renata.gruszka@biol.uni.lodz.pl](renata.gruszka@biol.uni.lodz.pl) (R.G.); [renata.kontek@biol.uni.lodz.pl](renata.kontek@biol.uni.lodz.pl) (R.K.)  \n2 Doctoral School of Exact and Natural Sciences, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland  \n3 Laboratory of Microscopic Imaging and Specialized Biological Techniques, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland; [sebastian.wawrocki@biol.uni.lodz.pl](sebastian.wawrocki@biol.uni.lodz.pl)  \n* [Correspondence: mateusz.kciuk@biol.uni.lodz.pl](Correspondence: mateusz.kciuk@biol.uni.lodz.pl)  \nAbstract  \nNatural compounds are increasingly recognized as valuable sources of pharmacologically active agents for cancer therapy. Among them, plant-derived triterpenoids attract attention due to their structural diversity and broad biological activity. Roburic acid (RA), atetracyclic triterpenoid, has previously been shown to exert antiproliferative effects in colorectal cancer (CRC) cells with limited cytotoxicity. In the present study, we investigated the cellular mechanisms underlying RA activity in CRC cells, focusing on cell cycle regulation, mitochondrial function, apoptosis, oxidative stress, and DNA integrity. RA treatment markedly suppressed CRC cell proliferation, resulting in G 0/G1 cell cycle arrest and downregulation of key proliferation markers. Mitochondrial analysis revealed an early reduction in mitochondrial membrane potential (MMP) following RA exposure, indicating mitochondrial dysfunction. Importantly, these effects occurred in the absence of intracellular reactive oxygen species (ROS) generation and without induction of DNA strand breaks, demonstrating a non-pro-oxidant and non-genotoxic profile of RA. Apoptotic features were observed mainly at higher concentrations and after prolonged exposure and were strongly dependent on cell line and assay type. Overall, RA limits CRC cell growth predominantly through cytostatic mechanisms, including cell cycle arrest and mitochondrial modulation, while apoptosis is a secondary, context-dependent response. The lack of oxidative stress and genotoxicity distinguishes RA from many conventional cytotoxic agents and supports its further investigation as a non-genotoxic anticancer compound.  \nKeywords: roburic acid; colorectal cancer; cytostatic activity; cell cycle arrest; mitochondrial dysfunction; anti-proliferative activity  \n1. Introduction  \nColorectal cancer (CRC) remains one of the most frequently diagnosed malignancies worldwide and represents a major global health burden. According to the most recent GLOBOCAN 2022 estimates, CRC accounts for approximately 1.9 million new cases andover 930,000 deaths annually, ranking third in global cancer incidence and second in cancer-related mortality [1] . Although incidence rates are stabilizing or declining in some high-income countries due to screening programs, CRC incidence continues to rise in  \nmany low-and middle-income regions. Notably, an alarming increase in early-onset CRChas been observed in individuals under 50 years of age, particularly in developed countries, suggesting shifts in environmental, lifestyle, and metabolic risk factors [2] . Despite advances in surgical te","cbCainPI6gjKycRA","https://ap.wps.com/l/cbCainPI6gjKycRA","pdf",3669222,26,"English","# Introduction\n## Roburic Acid and Background\n## Study Rationale and Cytostatic Focus","[{\"question\":\"How does roburic acid (RA) affect colorectal cancer cell proliferation?\",\"answer\":\"RA markedly suppresses CRC cell proliferation, primarily by inducing G0/G1 cell cycle arrest and downregulating key proliferation markers.\"},{\"question\":\"What mitochondrial and oxidative stress effects does RA cause?\",\"answer\":\"RA causes an early reduction in mitochondrial membrane potential, indicating mitochondrial dysfunction, while occurring without intracellular reactive oxygen species (ROS) generation.\"},{\"question\":\"Is RA genotoxic or does it induce DNA strand breaks?\",\"answer\":\"RA shows a non-genotoxic profile: its effects occur without induction of DNA strand breaks, supporting further investigation as a non-genotoxic anticancer compound.\"}]","Roburic Acid as a Therapeutic Candidate - Antiproliferative Activity and Secondary Cell Death Response in Colorectal Cancer Cells | PDF",1790100266,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d121003925accbb34b52fca32359d770.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b24e3b0b1d245e55ab750574c107780c.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cf357f69be99e3139f1567d26e11b81.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36152a79671c6f6dcb99b1e6cabb854c.webp",980,1385]